These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 35993319)

  • 21. Effectiveness of aripiprazole, olanzapine, quetiapine, and risperidone augmentation treatment for major depressive disorder: a nationwide population-based study.
    Lin CY; Tsai GE; Wang HS; Wu YH; Chiou CC; Wu VY; Lane HY
    J Clin Psychiatry; 2014 Sep; 75(9):e924-31. PubMed ID: 25295435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis.
    Zhou X; Keitner GI; Qin B; Ravindran AV; Bauer M; Del Giovane C; Zhao J; Liu Y; Fang Y; Zhang Y; Xie P
    Int J Neuropsychopharmacol; 2015 May; 18(11):pyv060. PubMed ID: 26012350
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative efficacy and tolerability of pharmacological interventions for acute bipolar depression in adults: a systematic review and network meta-analysis.
    Yildiz A; Siafis S; Mavridis D; Vieta E; Leucht S
    Lancet Psychiatry; 2023 Sep; 10(9):693-705. PubMed ID: 37595997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy and safety of 4 atypical antipsychotics augmentation treatment for major depressive disorder in adults: A systematic review and network meta-analysis.
    Wang J; Li W; Li M; Wu H; Qiu Z
    Medicine (Baltimore); 2023 Sep; 102(38):e34670. PubMed ID: 37746943
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A systematic review and network meta-analysis on comparative efficacy, acceptability, and safety of treatments in acute bipolar mania in youths.
    Tural Hesapcioglu S; Kasak M; Abursu H; Kafali S; Ceylan MF; Akyol M
    J Affect Disord; 2024 Mar; 349():438-451. PubMed ID: 38211745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maximizing response to first-line antipsychotics in schizophrenia: a review focused on finding from meta-analysis.
    Smith RC; Leucht S; Davis JM
    Psychopharmacology (Berl); 2019 Feb; 236(2):545-559. PubMed ID: 30506237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and dropout rates of antipsychotic medications for methamphetamine psychosis: A systematic review and network meta-analysis.
    Srisurapanont M; Likhitsathian S; Suttajit S; Maneeton N; Maneeton B; Oon-Arom A; Suradom C
    Drug Alcohol Depend; 2021 Feb; 219():108467. PubMed ID: 33385693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer's disease.
    Ballard C; Waite J
    Cochrane Database Syst Rev; 2006 Jan; (1):CD003476. PubMed ID: 16437455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of pharmacological and non-pharmacological interventions on physical health outcomes in people with mood disorders across the lifespan: An umbrella review of the evidence from randomised controlled trials.
    Croatto G; Vancampfort D; Miola A; Olivola M; Fiedorowicz JG; Firth J; Alexinschi O; Gaina MA; Makkai V; Soares FC; Cavaliere L; Vianello G; Stubbs B; Fusar-Poli P; Carvalho AF; Vieta E; Cortese S; Shin JI; Correll CU; Solmi M
    Mol Psychiatry; 2023 Jan; 28(1):369-390. PubMed ID: 36138129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and tolerability of FDA-approved atypical antipsychotics for the treatment of bipolar depression: a systematic review and network meta-analysis.
    Li S; Xu C; Hu S; Lai J
    Eur Psychiatry; 2024 Mar; 67(1):e29. PubMed ID: 38487836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systematic review of augmentation strategies for patients with major depressive disorder.
    Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
    Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and Tolerability of Atypical Antipsychotics in the Treatment of Delirium: A Systematic Review of the Literature.
    Rivière J; van der Mast RC; Vandenberghe J; Van Den Eede F
    Psychosomatics; 2019; 60(1):18-26. PubMed ID: 30181002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta-analysis.
    Rummel-Kluge C; Komossa K; Schwarz S; Hunger H; Schmid F; Lobos CA; Kissling W; Davis JM; Leucht S
    Schizophr Res; 2010 Nov; 123(2-3):225-33. PubMed ID: 20692814
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Are antipsychotics effective adjunctive Tx for patients with moderate-to-severe depression?
    Bleacher H; Koerperich L; Malam N; DeSanto K
    J Fam Pract; 2022 Jul; 71(6):E13-E15. PubMed ID: 35994758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-World Data on the Adverse Metabolic Effects of Second-Generation Antipsychotics and Their Potential Determinants in Adult Patients: A Systematic Review of Population-Based Studies.
    Bernardo M; Rico-Villademoros F; García-Rizo C; Rojo R; Gómez-Huelgas R
    Adv Ther; 2021 May; 38(5):2491-2512. PubMed ID: 33826090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    Jin B; Liu H
    J Neurol; 2019 Oct; 266(10):2363-2375. PubMed ID: 30666436
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis.
    Demyttenaere K; Detraux J; Racagni G; Vansteelandt K
    CNS Drugs; 2019 Jun; 33(6):549-566. PubMed ID: 31065941
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.